The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A phase III randomized controlled trial of short-course radiotherapy with or without concomitant and adjuvant temozolomide in elderly patients with glioblastoma (NCIC CTG CE.6, EORTC 26062-22061, TROG 08.02, NCT00482677).
James R. Perry
No relevant relationships to disclose
Christopher J O'Callaghan
No relevant relationships to disclose
Keyue Ding
No relevant relationships to disclose
Wilson Roa
No relevant relationships to disclose
Warren P. Mason
No relevant relationships to disclose
J. Gregory Cairncross
No relevant relationships to disclose
Alba Ariela Brandes
No relevant relationships to disclose
Johan Menten
No relevant relationships to disclose
Claire Phillips
No relevant relationships to disclose
Michael F. Fay
No relevant relationships to disclose
Ryo Nishikawa
No relevant relationships to disclose
Chad Winch
No relevant relationships to disclose
Normand Laperriere
No relevant relationships to disclose